{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:47:10Z","timestamp":1792446430184,"version":"4.5.0"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Colloid and Interface Science"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cis.2026.103954","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:09:04Z","timestamp":1779750544000},"page":"103954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Beyond the brain barrier: Hybrid nanoparticles orchestrating intelligent neuro-theranostics"],"prefix":"10.1016","volume":"356","author":[{"given":"Shubhi","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskiran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cis.2026.103954_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165-166","author":"Pandit","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"13","key":"10.1016\/j.cis.2026.103954_bb0010","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2174\/1568026616666161222101355","article-title":"Nanocarriers for effective brain drug delivery","volume":"17","author":"Comoglu","year":"2017","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.2009.05108.x","article-title":"Advances in the treatment of neurodegenerative disorders employing nanotechnology","volume":"1184","author":"Modi","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cis.2026.103954_bb0020","article-title":"Advances in nanoparticles in targeted drug delivery \u2013 a review","volume":"19","author":"Islam","year":"2025","journal-title":"Results Surf Interfaces"},{"issue":"7","key":"10.1016\/j.cis.2026.103954_bb0025","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/ijms18071415","article-title":"Theranostic liposome\u2013nanoparticle hybrids for drug delivery and bioimaging","volume":"18","author":"Seleci","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/adv\/4707146","article-title":"Polymer\u2013lipid hybrid nanosystems: an emerging advanced therapeutic tool","volume":"2025","author":"Okafor","year":"2025","journal-title":"Adv Polym Technol"},{"key":"10.1016\/j.cis.2026.103954_bb0035","article-title":"Lipid\u2013polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives","volume":"1937-52","author":"Mukherjee","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","article-title":"Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics","volume":"22","author":"Gajbhiye","year":"2023","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0045","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1038\/s41598-022-09317-3","article-title":"Multimodal bioimaging using nanodiamond and gold hybrid nanoparticles","volume":"12","author":"Lin","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cis.2026.103954_bb0050","series-title":"Cholesterol-laden brain-permeable nanoparticles support long-lasting cognitive recovery and motor amelioration in the slow-progressing zQ175DN mouse model of Huntington\u2019s Disease","author":"Birolini","year":"2022"},{"issue":"16","key":"10.1016\/j.cis.2026.103954_bb0055","article-title":"Putting hybrid nanomaterials to work for biomedical applications","volume":"63","author":"Zhang","year":"2024","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cis.2026.103954_bb0060","article-title":"Bionic design based on liposome-exosome hybrid nanoparticles for synergistic delivery of paeonol to achieve neuroprotection and improvement of motor function in Parkinson\u2019s disease model mice","volume":"37","author":"Wu","year":"2026","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.cis.2026.103954_bb0065","article-title":"Primary studies on construction and evaluation of ion-sensitive in situ gel loaded with paeonol-solid lipid nanoparticles for intranasal drug delivery","volume":"3137-60","author":"Sun","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.cis.2026.103954_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2023.06.001","article-title":"Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability","volume":"359","author":"Lu","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.103954_bb0075","article-title":"Edaravone delivery of exosome-liposome hybrid nanoparticles for the treatment of ischemic stroke","volume":"38","author":"Zhu","year":"2026","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.cis.2026.103954_bb0080","article-title":"Combating intracellular pathogens with nanohybrid-facilitated antibiotic delivery","volume":"8437-49","author":"Bose","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0085","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1080\/10717544.2017.1410263","article-title":"Stealth lipid polymer hybrid nanoparticles loaded with rutin for effective brain delivery \u2013 comparative study with the gold standard (Tween 80): optimization, characterization and biodistribution","volume":"24","author":"Ishak","year":"2017","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.cis.2026.103954_bb0090","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nano.2017.11.008","article-title":"Artificial apolipoprotein corona enables nanoparticle brain targeting","volume":"14","author":"Dal Magro","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.cis.2026.103954_bb0095","first-page":"129","article-title":"Polymer -lipid hybrid nanoparticles for brain targeting through intranasal delivery","volume":"7","author":"Arya","year":"2017","journal-title":"J Drug Deliv Ther"},{"issue":"8","key":"10.1016\/j.cis.2026.103954_bb0100","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1166\/jbn.2013.1536","article-title":"Surface functionalized gold nanoparticles for drug delivery","volume":"9","author":"Cheng","year":"2013","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.cis.2026.103954_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1137096","article-title":"Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review","volume":"17","author":"Won","year":"2023","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0110","article-title":"Blood-brain barrier overview: structural and functional correlation","volume":"2021","author":"Alahmari","year":"2021","journal-title":"Neural Plast"},{"key":"10.1016\/j.cis.2026.103954_bb0115","series-title":"The Neurology of AIDS","first-page":"0","article-title":"Blood-brain barrier structure and function","author":"Banks","year":"2011"},{"key":"10.1016\/j.cis.2026.103954_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2025.103401","article-title":"The endothelial surface layer-glycocalyx - Universal nano-infrastructure is fundamental to physiology, cell traffic and a complementary neural network","volume":"338","author":"Ninham","year":"2025","journal-title":"Adv Colloid Interf Sci"},{"issue":"6","key":"10.1016\/j.cis.2026.103954_bb0125","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ca.23083","article-title":"Blood brain barrier: a review of its anatomy and physiology in health and disease","volume":"31","author":"Sharif","year":"2018","journal-title":"Clin Anat"},{"key":"10.1016\/j.cis.2026.103954_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2015.01.002","article-title":"Anatomy and physiology of the blood\u2013brain barrier","volume":"38","author":"Serlin","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0135","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2020.1840913","article-title":"Basic physiology of the blood-brain barrier in health and disease: a brief overview","volume":"9","author":"Kaya","year":"2021","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.cis.2026.103954_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109960","article-title":"Advances in designing of polymeric micelles for biomedical application in brain related diseases","volume":"361","author":"Kaur","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"46","key":"10.1016\/j.cis.2026.103954_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood\u2013brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv Mater"},{"issue":"15","key":"10.1016\/j.cis.2026.103954_bb0150","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.3390\/ijms25158404","article-title":"The glycocalyx: the importance of sugar coating the blood-brain barrier","volume":"25","author":"Dancy","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2\u20133","key":"10.1016\/j.cis.2026.103954_bb0155","first-page":"131","article-title":"Endothelial barrier reinforcement relies on flow-regulated glycocalyx, a potential therapeutic target","volume":"56","author":"Harding","year":"2019","journal-title":"Biorheology"},{"key":"10.1016\/j.cis.2026.103954_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.739699","article-title":"The structure and function of the glycocalyx and its connection with blood-brain barrier","volume":"15","author":"Jin","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/cns.13560","article-title":"Endothelial glycocalyx as an important factor in composition of blood-brain barrier","volume":"27","author":"Zhao","year":"2021","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10.1016\/j.cis.2026.103954_bb0170","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2021.1904773","article-title":"Surface charge, glycocalyx, and blood-brain barrier function","volume":"9","author":"Walter","year":"2021","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.cis.2026.103954_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.754141","article-title":"The role of heparin and glycocalyx in blood\u2013brain barrier dysfunction","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.cis.2026.103954_bb0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00401-018-1807-1","article-title":"Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease","volume":"135","author":"Ghersi-Egea","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.cis.2026.103954_bb0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nbd.2016.08.011","article-title":"The choroid plexus in health and in disease: dialogues into and out of the brain","volume":"107","author":"Marques","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.cis.2026.103954_bb0190","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s13346-025-01887-9","article-title":"Crossing the blood\u2013brain barrier: nanoparticle-based strategies for neurodegenerative disease therapy","volume":"16","author":"Haro-Mart\u00ednez","year":"2026","journal-title":"Drug Deliv Transl Res"},{"issue":"8","key":"10.1016\/j.cis.2026.103954_bb0195","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/ph17081070","article-title":"Advances in intrathecal nanoparticle delivery: targeting the blood\u2013cerebrospinal fluid barrier for enhanced CNS drug delivery","volume":"17","author":"Madadi","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cis.2026.103954_bb0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.201412147","article-title":"Brain barriers: crosstalk between complex tight junctions and adherens junctions","volume":"209","author":"Tietz","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cis.2026.103954_bb0205","series-title":"The blood-brain barrier and its microenvironment","first-page":"47","article-title":"Tight junctions of the blood-brain barrier","author":"Kooij","year":"2005"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1006995910836","article-title":"Tight junctions of the blood-brain barrier","volume":"20","author":"Kniesel","year":"2000","journal-title":"Cell Mol Neurobiol"},{"issue":"7","key":"10.1016\/j.cis.2026.103954_bb0215","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s11095-013-1289-8","article-title":"Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood\u2013brain barrier","volume":"31","author":"Hsu","year":"2014","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0220","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood\u2013brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cis.2026.103954_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101665","article-title":"Targeting the transferrin receptor for brain drug delivery","volume":"181","author":"Johnsen","year":"2019","journal-title":"Prog Neurobiol"},{"issue":"2","key":"10.1016\/j.cis.2026.103954_bb0230","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ada85e","article-title":"Transcytosis: an effective mechanism to enhance nanoparticle extravasation and infiltration through biological barriers","volume":"20","author":"Zhang","year":"2025","journal-title":"Biomed Mater"},{"issue":"S1","key":"10.1016\/j.cis.2026.103954_bb0235","article-title":"Nanoparticle internalization and transport by caveolae","volume":"24","author":"Wang","year":"2010","journal-title":"FASEB J"},{"issue":"8","key":"10.1016\/j.cis.2026.103954_bb0240","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/iub.485","article-title":"Delivery of nanoparticle-complexed drugs across the vascular endothelial barrier via caveolae","volume":"63","author":"Wang","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.cis.2026.103954_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114286","article-title":"Lipid and polymeric nanocarriers for siRNA delivery to the brain","volume":"388","author":"Koirala","year":"2025","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.cis.2026.103954_bb0250","article-title":"Caveolae-mediated delivery of therapeutic nanoparticles across blood-endothelial barrier","volume":"1","author":"Wang","year":"2014","journal-title":"Austin J Anal Pharm Chem"},{"issue":"9","key":"10.1016\/j.cis.2026.103954_bb0255","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/pharmaceutics17091169","article-title":"Cracking the blood\u2013brain barrier code: rational nanomaterial design for next-generation neurological therapies","volume":"17","author":"N\u00e1jera-Maldonado","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cis.2026.103954_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114403","article-title":"Nanoparticle entry into cells; the cell biology weak link","volume":"188","author":"Griffiths","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.103954_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2026.115612","article-title":"Recent advances in polymeric nanoparticle-mediated drug delivery system across the blood-brain barrier in Alzheimer\u2019s disease","volume":"263","author":"Rajkumar","year":"2026","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1016\/j.cis.2026.103954_bb0270","article-title":"Nanotechnology for neurodegenerative diseases: recent progress in brain-targeted delivery, stimuli-responsive platforms, and organelle-specific therapeutics","volume":"11015-44","author":"Gao","year":"2025","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0275","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12951-025-03528-2","article-title":"Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges","volume":"23","author":"Sanadgol","year":"2025","journal-title":"J Nanobiotechnol"},{"issue":"19","key":"10.1016\/j.cis.2026.103954_bb0280","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2217\/nnm-2017-0193","article-title":"Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma","volume":"12","author":"Lu","year":"2017","journal-title":"Nanomedicine"},{"issue":"21","key":"10.1016\/j.cis.2026.103954_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102519","article-title":"A framework of paracellular transport via nanoparticles-induced endothelial leakiness","volume":"8","author":"Lee","year":"2021","journal-title":"Adv Sci"},{"issue":"10","key":"10.1016\/j.cis.2026.103954_bb0290","doi-asserted-by":"crossref","first-page":"15627","DOI":"10.1021\/acsnano.2c05317","article-title":"How nanoparticles open the paracellular route of biological barriers: mechanisms, applications, and prospects","volume":"16","author":"Wu","year":"2022","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.cis.2026.103954_bb0295","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1248\/bpb.b12-00769","article-title":"The permeability of puerarin loaded poly (butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood\u2013brain barrier and its protective effect against cerebral ischemia\/reperfusion injury","volume":"36","author":"Zhao","year":"2013","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1016\/j.cis.2026.103954_bb0300","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v22.i4.10","article-title":"Modification of epithelial tight junction integrity to enhance transmucosal absorption","volume":"22","author":"Mrsny","year":"2005","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0305","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.foodres.2012.12.038","article-title":"Modulation of tight junction integrity by food components","volume":"54","author":"Kosi\u0144ska","year":"2013","journal-title":"Food Res Int"},{"key":"10.1016\/j.cis.2026.103954_bb0310","series-title":"Permeability Barrier: Methods and Protocols","first-page":"13","article-title":"Rapid evaluation of intestinal paracellular permeability using the human enterocytic-like Caco-2\/TC7 cell line","author":"Postal","year":"2021"},{"issue":"2","key":"10.1016\/j.cis.2026.103954_bb0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0320","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/bc00031a015","article-title":"Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media","volume":"6","author":"Nakajima","year":"1995","journal-title":"Bioconjug Chem"},{"issue":"3","key":"10.1016\/j.cis.2026.103954_bb0325","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herv\u00e9","year":"2008","journal-title":"AAPS J"},{"issue":"130","key":"10.1016\/j.cis.2026.103954_bb0330","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003162","article-title":"Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model","volume":"4","author":"Kannan","year":"2012","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.cis.2026.103954_bb0335","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/jps.23928","article-title":"Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly (ethylene glycol)-co-poly (trimethylene carbonate) polymer nanoparticles","volume":"103","author":"Jiang","year":"2014","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.cis.2026.103954_bb0340","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","article-title":"Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery","volume":"54","author":"Patching","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.cis.2026.103954_bb0345","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1166\/jbn.2012.1462","article-title":"Comparative receptor based brain delivery of tramadol-loaded poly (lactic-co-glycolic acid) nanoparticles","volume":"8","author":"Lalani","year":"2012","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0350","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1038\/s41598-019-44569-6","article-title":"Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood\u2013brain barrier penetration","volume":"9","author":"Khongkow","year":"2019","journal-title":"Sci Rep"},{"issue":"68","key":"10.1016\/j.cis.2026.103954_bb0355","doi-asserted-by":"crossref","first-page":"41471","DOI":"10.1039\/D0RA07161G","article-title":"A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles","volume":"10","author":"Qiao","year":"2020","journal-title":"RSC Adv"},{"issue":"33","key":"10.1016\/j.cis.2026.103954_bb0360","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1016\/j.biomaterials.2013.07.075","article-title":"Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment","volume":"34","author":"Cui","year":"2013","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.cis.2026.103954_bb0365","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1021\/acsomega.8b00152","article-title":"Development of doxorubicin-loaded magnetic silica\u2013pluronic F-127 nanocarriers conjugated with transferrin for treating glioblastoma across the blood\u2013brain barrier using an in vitro model","volume":"3","author":"Heggannavar","year":"2018","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0370","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12951-018-0340-7","article-title":"ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood\u2013brain barrier","volume":"16","author":"Shen","year":"2018","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0375","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/cm402180t","article-title":"The thiol-Michael addition click reaction: a powerful and widely used tool in materials chemistry","volume":"26","author":"Nair","year":"2014","journal-title":"Chem Mater"},{"issue":"4","key":"10.1016\/j.cis.2026.103954_bb0380","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1039\/b901970g","article-title":"Cu-free click cycloaddition reactions in chemical biology","volume":"39","author":"Jewett","year":"2010","journal-title":"Chem Soc Rev"},{"issue":"46","key":"10.1016\/j.cis.2026.103954_bb0385","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1021\/ja044996f","article-title":"A strain-promoted [3+ 2] azide\u2212 alkyne cycloaddition for covalent modification of biomolecules in living systems","volume":"126","author":"Agard","year":"2004","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0390","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2011.01.030","article-title":"Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery","volume":"152","author":"Cheng","year":"2011","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.cis.2026.103954_bb0395","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(02)00179-5","article-title":"Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities","volume":"55","author":"Saito","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"39","key":"10.1016\/j.cis.2026.103954_bb0400","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1002\/anie.200802651","article-title":"Hydrolytic stability of hydrazones and oximes","volume":"47","author":"Kalia","year":"2008","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.cis.2026.103954_bb0405","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.cis.2026.103954_bb0410","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","article-title":"Progress and perspectives on targeting nanoparticles for brain drug delivery","volume":"6","author":"Gao","year":"2016","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0415","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1007\/s12672-025-03471-6","article-title":"Quantitative assessment of the associations between MTR and MTRR gene polymorphisms and glioma risk","volume":"16","author":"Chen","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.cis.2026.103954_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114822","article-title":"Magnetic iron oxide nanoparticles for brain imaging and drug delivery","volume":"197","author":"Qiao","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"10.1016\/j.cis.2026.103954_bb0425","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1021\/acs.nanolett.4c05470","article-title":"A brain-targeting NIR-II polymeric phototheranostic nanoplatform toward orthotopic drug-resistant glioblastoma","volume":"25","author":"Su","year":"2025","journal-title":"Nano Lett"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0430","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1039\/C7RA12376K","article-title":"Facile construction of dual-targeting delivery system by using lipid capped polymer nanoparticles for anti-glioma therapy","volume":"8","author":"Wang","year":"2018","journal-title":"RSC Adv"},{"key":"10.1016\/j.cis.2026.103954_bb0435","series-title":"Polymer-lipid hybrid nanoparticles for brain targeting throughintranasal delivery","author":"Kant","year":"2011"},{"issue":"6","key":"10.1016\/j.cis.2026.103954_bb0440","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"4","key":"10.1016\/j.cis.2026.103954_bb0445","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.cis.2026.103954_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306675","article-title":"Hybrid membrane-coated nanoparticles for precise targeting and synergistic therapy in Alzheimer\u2019s disease","volume":"11","author":"Lin","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.cis.2026.103954_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2017.08.006","article-title":"Current strategies for the delivery of therapeutic proteins and enzymes to treat brain disorders","volume":"137","author":"Duskey","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.cis.2026.103954_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.939855","article-title":"Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer\u2019s disease: current trends and future perspectives","volume":"16","author":"La Barbera","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cis.2026.103954_bb0465","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejmech.2014.04.050","article-title":"Multifunctional nanoliposomes with curcumin\u2013lipid derivative and brain targeting functionality with potential applications for Alzheimer disease","volume":"80","author":"Mourtas","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.cis.2026.103954_bb0470","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ymthe.2024.03.024","article-title":"APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease","volume":"32","author":"Jackson","year":"2024","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.cis.2026.103954_bb0475","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"9996","key":"10.1016\/j.cis.2026.103954_bb0480","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cis.2026.103954_bb0485","series-title":"Advances in neurotherapeutic delivery technologies","first-page":"3","article-title":"Nanovectors for neurotherapeutic delivery part II: polymeric nanoparticles","author":"Pitorre","year":"2015"},{"issue":"4","key":"10.1016\/j.cis.2026.103954_bb0490","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2174\/1570159X14666151230124904","article-title":"Drug delivery systems for imaging and therapy of Parkinson\u2019s disease","volume":"14","author":"Silindir Gunay","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.cis.2026.103954_bb0495","article-title":"On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Appl Mater Today"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0500","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40820-022-00847-z","article-title":"Anti-Parkinsonian therapy: strategies for crossing the blood\u2013brain barrier and nano-biological effects of nanomaterials","volume":"14","author":"Cheng","year":"2022","journal-title":"Nano Micro Lett"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0505","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12035-017-0728-7","article-title":"Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson\u2019s disease","volume":"55","author":"Hernando","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"7","key":"10.1016\/j.cis.2026.103954_bb0510","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/bios11070218","article-title":"Lipid\u2013polymer hybrids encapsulating iron-oxide nanoparticles as a label for lateral flow immunoassays","volume":"11","author":"Bazsefidpar","year":"2021","journal-title":"Biosensors"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0515","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Prim"},{"issue":"10","key":"10.1016\/j.cis.2026.103954_bb0520","article-title":"In vivo progressive degeneration of Huntington\u2019s disease patient-derived neurons reveals human-specific pathological phenotypes","volume":"2020","author":"Miguez","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cis.2026.103954_bb0525","first-page":"5","article-title":"Design, characterization, and lead selection of therapeutic miRNAs targeting huntingtin for development of gene therapy for Huntington\u2019s disease","author":"Miniarikova","year":"2016","journal-title":"Mol Ther Nucl Acids"},{"issue":"4","key":"10.1016\/j.cis.2026.103954_bb0530","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cis.2026.103954_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"Van Tellingen","year":"2015","journal-title":"Drug Resist Updat"},{"issue":"12","key":"10.1016\/j.cis.2026.103954_bb0540","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/acscentsci.4c01173","article-title":"Cyclic ruthenium-peptide prodrugs penetrate the blood\u2013brain barrier and attack glioblastoma upon light activation in orthotopic zebrafish tumor models","volume":"10","author":"Zhang","year":"2024","journal-title":"ACS Cent Sci"},{"issue":"21","key":"10.1016\/j.cis.2026.103954_bb0545","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.1307152110","article-title":"Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor","volume":"110","author":"Wiley","year":"2013","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.cis.2026.103954_bb0550","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-010-0389-0","article-title":"Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme","volume":"103","author":"Maier-Hauff","year":"2011","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.cis.2026.103954_bb0555","article-title":"Gene therapy for drug-resistant glioblastoma via lipid-polymer hybrid nanoparticles combined with focused ultrasound","volume":"185-99","author":"Yang","year":"2021","journal-title":"Int J Nanomedicine"},{"issue":"15","key":"10.1016\/j.cis.2026.103954_bb0560","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.18632\/oncotarget.7896","article-title":"The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cis.2026.103954_bb0565","first-page":"396","article-title":"Engineered smart materials for RNA based molecular therapy to treat Glioblastoma","volume":"33","author":"Singh","year":"2024","journal-title":"Bioact Mater"},{"issue":"12","key":"10.1016\/j.cis.2026.103954_bb0570","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1007\/s11095-015-1748-5","article-title":"PLGA-based nanoparticles: a safe and suitable delivery platform for osteoarticular pathologies: Riffault et al","volume":"32","author":"Riffault","year":"2015","journal-title":"Pharm Res"},{"issue":"5\u20136","key":"10.1016\/j.cis.2026.103954_bb0575","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1039\/b904878b","article-title":"Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides","volume":"1","author":"Aguilera","year":"2009","journal-title":"Integr Biol"},{"key":"10.1016\/j.cis.2026.103954_bb0580","article-title":"Brain targeting nanomedicines: pitfalls and promise","volume":"4857-75","author":"Kakinen","year":"2024","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"10.1016\/j.cis.2026.103954_bb0585","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/17425247.2015.1041374","article-title":"Nanomedicine and neurodegenerative disorders: so close yet so far","volume":"12","author":"Tosi","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0590","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7150\/ntno.88849","article-title":"Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer","volume":"8","author":"Rafe","year":"2024","journal-title":"Nanotheranostics"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0595","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/157341309787314665","article-title":"Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases","volume":"5","author":"Baratchi","year":"2009","journal-title":"Curr Nanosci"},{"issue":"24","key":"10.1016\/j.cis.2026.103954_bb0600","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1039\/D2NA00524G","article-title":"Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson\u2019s disease","volume":"4","author":"Alabrahim","year":"2022","journal-title":"Nanoscale Adv"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0605","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41531-025-01081-1","article-title":"Revamping Parkinson\u2019s disease therapy using PLGA-based drug delivery systems","volume":"11","author":"Lababidi","year":"2025","journal-title":"npj Parkinson\u2019s Dis"},{"key":"10.1016\/j.cis.2026.103954_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00494","article-title":"Nanotechnology: a promising approach for delivery of neuroprotective drugs","volume":"14","author":"Naqvi","year":"2020","journal-title":"Front Neurosci"},{"issue":"4s","key":"10.1016\/j.cis.2026.103954_bb0615","doi-asserted-by":"crossref","first-page":"s1185","DOI":"10.5530\/ijper.58.4s.116","article-title":"Nanotechnology-driven approaches in overcoming drug delivery challenges for neurodegenerative diseases","volume":"58","author":"Palaniyappan","year":"2024","journal-title":"Indian J Pharm Educ Res"},{"issue":"6","key":"10.1016\/j.cis.2026.103954_bb0620","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/smll.201201870","article-title":"Shuttle-mediated nanoparticle delivery to the blood\u2013brain barrier","volume":"9","author":"Guarnieri","year":"2013","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.cis.2026.103954_bb0625","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3329\/ijpls.v2i3.15457","article-title":"Drug delivery to the brain using polymeric nanoparticles: a review","volume":"2","author":"Bhatt","year":"2013","journal-title":"Int J Pharm Life Sci"},{"key":"10.1016\/j.cis.2026.103954_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.612692","article-title":"Nano-neurotheranostics: impact of nanoparticles on neural dysfunctions and strategies to reduce toxicity for improved efficacy","volume":"12","author":"Vinod","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0635","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40824-019-0166-x","article-title":"Therapeutic efficacy of nanoparticles and routes of administration","volume":"23","author":"Chenthamara","year":"2019","journal-title":"Biomater Res"},{"issue":"10","key":"10.1016\/j.cis.2026.103954_bb0640","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1021\/acsnano.5b05341","article-title":"Penetrating the blood\u2013brain barrier: promise of novel nanoplatforms and delivery vehicles","volume":"9","author":"Ali","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0645","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-8977-7-3","article-title":"Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging","volume":"7","author":"Bhaskar","year":"2010","journal-title":"Part Fibre Toxicol"},{"issue":"22","key":"10.1016\/j.cis.2026.103954_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39972","article-title":"Bi-modal confirmation of liposome delivery to the brain after focused ultrasound-induced blood-brain barrier opening","volume":"10","author":"Payne","year":"2024","journal-title":"Heliyon"},{"issue":"34","key":"10.1016\/j.cis.2026.103954_bb0655","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1073\/pnas.1003388107","article-title":"Magnetic resonance monitoring of focused ultrasound\/magnetic nanoparticle targeting delivery of therapeutic agents to the brain","volume":"107","author":"Liu","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cis.2026.103954_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107061","article-title":"Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: optimization and biodistribution study by radiobiological evaluation","volume":"208","author":"Albash","year":"2025","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.cis.2026.103954_bb0665","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/acsanm.2c05272","article-title":"PEGylated polymer\u2013lipid hybrid nanoparticles to enhance in vivo exposure and uptake of repaglinide in brain cells to treat diabetes-linked neurodegenerative disorders","volume":"6","author":"Wadhwa","year":"2023","journal-title":"ACS Appl Nano Mater"},{"key":"10.1016\/j.cis.2026.103954_bb0670","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2020.12.051","article-title":"Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington\u2019s disease","volume":"330","author":"Birolini","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.cis.2026.103954_bb0675","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.colsurfb.2014.12.045","article-title":"Tailored polymer\u2013lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting","volume":"126","author":"Agrawal","year":"2015","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"7","key":"10.1016\/j.cis.2026.103954_bb0680","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1039\/C2CS15261D","article-title":"Multifunctional nanoparticles for multimodal imaging and theragnosis","volume":"41","author":"Lee","year":"2012","journal-title":"Chem Soc Rev"},{"issue":"11","key":"10.1016\/j.cis.2026.103954_bb0685","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.addr.2010.07.009","article-title":"Nanoparticle-based theranostic agents","volume":"62","author":"Xie","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cis.2026.103954_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.103080","article-title":"Shape and surface modification dependent cellular interactions of gold nanoparticles in a 3D blood-brain-barrier supported neurospheroid model","volume":"97","author":"Tomak","year":"2025","journal-title":"Tissue Cell"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0695","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12951-015-0140-2","article-title":"Gold nanoparticles as multimodality imaging agents for brain gliomas","volume":"13","author":"Lai","year":"2015","journal-title":"J Nanobiotechnol"},{"issue":"32","key":"10.1016\/j.cis.2026.103954_bb0700","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1021\/ja203340u","article-title":"Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T 1 magnetic resonance imaging contrast agents","volume":"133","author":"Kim","year":"2011","journal-title":"J Am Chem Soc"},{"issue":"9","key":"10.1016\/j.cis.2026.103954_bb0705","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.1620145114","article-title":"Exceedingly small iron oxide nanoparticles as positive MRI contrast agents","volume":"114","author":"Wei","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"10.1016\/j.cis.2026.103954_bb0710","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.2967\/jnumed.114.146019","article-title":"Theranostic nanoparticles","volume":"55","author":"Chen","year":"2014","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.cis.2026.103954_bb0715","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2967\/jnumed.114.141861","article-title":"A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting","volume":"55","author":"P\u00e9rez-Medina","year":"2014","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0720","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejrad.2013.05.028","article-title":"Competitive advantage of PET\/MRI","volume":"83","author":"Jadvar","year":"2014","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0725","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2214\/AJR.15.14968","article-title":"Current status of Hybrid PET\/MRI in oncologic imaging","volume":"206","author":"Rosenkrantz","year":"2016","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.cis.2026.103954_bb0730","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jmri.25161","article-title":"Clinical application of PET\/MRI in oncology","volume":"44","author":"Sotoudeh","year":"2016","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.cis.2026.103954_bb0735","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5152\/dir.2014.14008","article-title":"Clinical applications of PET\/MRI: current status and future perspectives","volume":"20","author":"Nensa","year":"2014","journal-title":"Diagn Interv Radiol"},{"issue":"S1","key":"10.1016\/j.cis.2026.103954_bb0740","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.53730\/ijhs.v8nS1.15396","article-title":"Advancements in hybrid imaging techniques: enhancing diagnostic accuracy with PET\/MRI and PET\/CT","volume":"8","author":"Alanazi","year":"2024","journal-title":"Int J Health Sci"},{"issue":"11","key":"10.1016\/j.cis.2026.103954_bb0745","doi-asserted-by":"crossref","DOI":"10.1038\/nnano.2009.326","article-title":"Second window for in vivo imaging","volume":"4","author":"Smith","year":"2009","journal-title":"Nat Nanotechnol"},{"issue":"10","key":"10.1016\/j.cis.2026.103954_bb0750","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1021\/acsapm.0c00679","article-title":"Recent advances in conjugated polymer nanoparticles for NIR-II imaging and therapy","volume":"2","author":"Gao","year":"2020","journal-title":"ACS Appl Polym Mater"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0755","doi-asserted-by":"crossref","first-page":"0010","DOI":"10.1038\/s41551-016-0010","article-title":"Near-infrared fluorophores for biomedical imaging","volume":"1","author":"Hong","year":"2017","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"10.1016\/j.cis.2026.103954_bb0760","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nm.2721","article-title":"A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle","volume":"18","author":"Kircher","year":"2012","journal-title":"Nat Med"},{"issue":"271","key":"10.1016\/j.cis.2026.103954_bb0765","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010633","article-title":"Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging","volume":"7","author":"Harmsen","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cis.2026.103954_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105243","article-title":"Near-infrared II fluorescence-guided glioblastoma surgery targeting monocarboxylate transporter 4 combined with photothermal therapy","volume":"106","author":"Zhao","year":"2024","journal-title":"EBioMedicine"},{"issue":"15","key":"10.1016\/j.cis.2026.103954_bb0775","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1158\/0008-5472.CAN-09-1157","article-title":"Specific targeting of brain tumors with an optical\/magnetic resonance imaging nanoprobe across the blood-brain barrier","volume":"69","author":"Veiseh","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.cis.2026.103954_bb0780","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3174\/ajnr.A5124","article-title":"Multiparametric evaluation in differentiating glioma recurrence from treatment-induced necrosis using simultaneous 18F-FDG-PET\/MRI: a single-institution retrospective study","volume":"38","author":"Jena","year":"2017","journal-title":"Am J Neuroradiol"},{"issue":"22","key":"10.1016\/j.cis.2026.103954_bb0785","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1158\/1078-0432.CCR-06-0946","article-title":"Vascular targeted nanoparticles for imaging and treatment of brain tumors","volume":"12","author":"Reddy","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.cis.2026.103954_bb0790","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmat2398","article-title":"Biodegradable luminescent porous silicon nanoparticles for in vivo applications","volume":"8","author":"Park","year":"2009","journal-title":"Nat Mater"},{"issue":"584","key":"10.1016\/j.cis.2026.103954_bb0795","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference\u2013based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cis.2026.103954_bb0800","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2019.06.018","article-title":"Peptide-guided nanoparticles for glioblastoma targeting","volume":"308","author":"S\u00e4\u00e4lik","year":"2019","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.cis.2026.103954_bb0805","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/end.2021.0266","article-title":"Novel automated three-dimensional surgical planning tool and magnetic resonance imaging\/ultrasound fusion technology to perform nanoparticle ablation and cryoablation of the prostate for focal therapy","volume":"36","author":"Jue","year":"2022","journal-title":"J Endourol"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0810","article-title":"Clinical trials with pegylated liposomal doxorubicin in the treatment of ovarian cancer","volume":"2013","author":"Pisano","year":"2013","journal-title":"J Drug Deliv"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0815","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.137455","article-title":"Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease","volume":"326","author":"Begum","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cis.2026.103954_bb0820","series-title":"A lipid-polymer hybrid nanoparticle","author":"Sharma","year":"2026"},{"key":"10.1016\/j.cis.2026.103954_bb0825","article-title":"Biomimetic exosomes: a new generation of drug delivery system","volume":"10","author":"Wang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.cis.2026.103954_bb0830","series-title":"Mesoporous silica nanoparticules with lipid bilayer coating for cargo delivery Australia","author":"Xiangsheng","year":"2022"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0835","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acs.bioconjchem.6b00569","article-title":"Biointerfacing and applications of cell membrane-coated nanoparticles","volume":"28","author":"Kroll","year":"2017","journal-title":"Bioconjug Chem"},{"issue":"30","key":"10.1016\/j.cis.2026.103954_bb0840","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1002\/smll.201600624","article-title":"Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery","volume":"12","author":"Gao","year":"2016","journal-title":"Small"},{"issue":"9","key":"10.1016\/j.cis.2026.103954_bb0845","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/anie.200903924","article-title":"Thiol\u2013ene click chemistry","volume":"49","author":"Hoyle","year":"2010","journal-title":"Angew Chem Int Ed"},{"issue":"11","key":"10.1016\/j.cis.2026.103954_bb0850","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew Chem Int Ed"},{"issue":"9","key":"10.1016\/j.cis.2026.103954_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092208","article-title":"Machine learning for drug-target interaction prediction","volume":"23","author":"Chen","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.cis.2026.103954_bb0860","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41597-021-01069-5","article-title":"A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors","volume":"8","author":"Meng","year":"2021","journal-title":"Sci Data"},{"issue":"4","key":"10.1016\/j.cis.2026.103954_bb0865","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1039\/C8CS00457A","article-title":"Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)","volume":"48","author":"Wu","year":"2019","journal-title":"Chem Soc Rev"},{"issue":"19","key":"10.1016\/j.cis.2026.103954_bb0870","doi-asserted-by":"crossref","first-page":"10575","DOI":"10.1021\/acs.chemrev.5b00100","article-title":"Gold nanoparticles for in vitro diagnostics","volume":"115","author":"Zhou","year":"2015","journal-title":"Chem Rev"},{"issue":"11","key":"10.1016\/j.cis.2026.103954_bb0875","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat Nanotechnol"}],"container-title":["Advances in Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000186862600179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000186862600179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:38:26Z","timestamp":1786408706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000186862600179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":175,"alternative-id":["S000186862600179X"],"URL":"https:\/\/doi.org\/10.1016\/j.cis.2026.103954","relation":{},"ISSN":["0001-8686"],"issn-type":[{"value":"0001-8686","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the brain barrier: Hybrid nanoparticles orchestrating intelligent neuro-theranostics","name":"articletitle","label":"Article Title"},{"value":"Advances in Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cis.2026.103954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103954"}}